Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis

Brain Research

Volumn 761, Issue 2, 1997, Pages 244-249

  Fujii, Takeshi ^a   Yoshizawa, Masayuki ^a   Nakai, Katsuhiko ^a   Fujimoto, Kazuko ^a   Suzuki, Takeshi ^a   Kawashima, Koichiro ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

8 Hydroxy 2(di n propylamino)tetralin; Acetylcholine; Hippocampus; Microdialysis; NAN 190; Radioimmunoassay; Serotonin(1A) receptor

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN RECEPTOR;

ACETYLCHOLINE RELEASE; ARTICLE; CHOLINERGIC TRANSMISSION; ENZYME ACTIVITY; HIPPOCAMPUS; MICRODIALYSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACETYLCHOLINE; ANIMALS; CHOLINESTERASE INHIBITORS; HIPPOCAMPUS; LOCOMOTION; MALE; MICRODIALYSIS; PHYSOSTIGMINE; PIPERAZINES; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYNAPTIC TRANSMISSION;

EID: 0030790860     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00325-9     Document Type: Article

References (28)

1. L.E. Arvidsson, U. Hacksell, J.L. Nilsson, S. Hjorth, A. Carlsson, P. Lindberg, D. Sanchez, H. Wikstrom, 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist, J. Med. Chem. 24 (1981) 921-923.
2. H. Benveniste, J. Drejer, A. Schousboe, N.H. Diemer, Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat, J. Neurochem. 49 (1987) 729-734.
3. 3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs, Br. J. Pharmacol. 101 (1990) 448-452.
4. 1A receptors, Br. J. Pharmacol. 105 (1992) 720-726.
5. 1A receptor agonist, impairs performance in a passive avoidance task, Eur. J. Pharmacol. 211 (1992) 227-234.
6. 3 receptors, J. Neurochem. 62 (1994) 2254-2261.
7. S. Dilsaver, Cholinergic mechanisms in depression, Brain Res. Rev. 11 (1986) 285-316.
8. S.B. Dunnett, W.C. Low, S.D. Iversen, U. Stenevi, A. Bjorklund, Septal transplants restore maze learning in rats with fornix-fimbria lesions, Brain Res. 251 (1982) 335-348.
9. R.S. Farr, A quantitative immunochemical measure of the primary interaction between I × BSA and antibody, J. Infect. Dis. 103 (1958) 239-262.
10. G. Gillet, S. Ammor, G. Fillon, Serotonin inhibits acetylcholine release from rat striatum slices: evidence for a presynaptic receptor-mediated effect, J. Neurochem. 45 (1985) 1687-1691.
11. 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), Eur. J. Pharmacol. 154 (1988) 339-341.
12. H.L. Goldberg, R.J. Finnerty, The comparative efficacy of buspirone and diazepam in the treatment of anxiety, Am. J. Psychiatry 136 (1979) 1184-1187.
13. D. Hoyer, D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, E.J. Mylecharane, P.R. Saxena, P.P.A. Humphrey, VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacol. Rev. 46 (1994) 157-203.
14. Y. Ishii, J. Kojima, N. Ikeda, K. Kawashima, Effect of NIK-247 on basal concentrations of extracellular acetylcholine in the cerebral cortex of conscious, freely moving rats, Jpn. J. Pharmacol. 66 (1994) 289-293.
15. 1A receptor enhances acetylcholine release in conscious rats, J. Neurochem. 62 (1994) 1804-1808.
16. D. Janowsky, C. Risch, L. Judd, D. Parker and L. Huey, Physostigmine responses as marker in affective disorder patients, in: E. Usdin, I. Hanin (Eds.), Biological Markers in Psychiatry and Neurology, Pergamon, Oxford, 1982, pp. 253-259.
17. K. Kawashima, H. Ishikawa, M. Mochizuki, Radioimmunoassay for acetylcholine in the rat brain, J. Pharmacol. Methods 3 (1980) 115-123.
18. K. Kawashima, T. Hayakawa, Y. Kashima, T. Suzuki, K. Fujimoto, H. Oohata, Determination of acetylcholine release in the striatum of anesthetized rats using in vivo microdialysis and a radioimmunoassay, J. Neurochem. 57 (1991) 882-887.
19. K. Kawashima, A. Sato, M. Yoshizawa, T. Fujii, K. Fujimoto, T. Suzuki, Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats, Naunyn-Schmiedeberg's Arch. Pharmacol. 350 (1994) 523-528.
20. 1B receptors mediating inhibition of acetylcholine release, Eur. J. Pharmacol. 129 (1986) 333-337.
21. G. Maura, E. Fedele, M. Raiteri, Acetylcholine release from rat hippocampus slices is modulated by 5-hydroxytryptamine, Eur. J. Pharmacol. 165 (1989) 173-179.
22. G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Sydney, 1986.
23. 1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior, Eur. J. Pharmacol. 262 (1994) 77-90.
24. 1A receptor agonist, on cortical acetylcholine release, electrocortigram and body temperature in guinea pigs and rats, Eur. J. Pharmacol. 175 (1990) 219-223.
25. 1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats, J. Neurosci. 6 (1986) 3474-3482.
26. S. Wallenstein, C.L. Zucker, J.L. Fleiss, Some statistical methods useful in circulation research, Circ. Res. 47 (1980) 1-9.
27. B.H.C. Westerink, H.M. Hofsteede, G. Damsma, J.B. de Vries, The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis, Naunyn-Schmiedeberg's Arch. Pharmacol. 337 (1988) 373-378.
28. 1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo, J. Pharmacol. Exp. Ther. 270 (1994) 656-664.